Study describes health outcomes following simultaneous vaccination with monovalent primary series COVID-19 vaccines

FHS
June 19, 2023
11:55 am

Researchers described simultaneous vaccination with primary series SARS-CoV-2 vaccines

Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product | Psychedelic Invest

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused

June 11, 2024

Exclusive: German biotech declares Phase 2 win for non-opioid drug for neuropathic pain

Algiax Pharmaceuticals’ non-opioid candidate has achieved “clinically meaningful” pain reduction in a mid-stage trial of people with peripheral post-surgical neuropathic pain, marking another success in

February 4, 2025

Ancient viral sequences in the human genome may contribute to psychiatric disorder susceptibility

New research led by King’s College London has found that thousands of DNA sequences originating from ancient viral infections are expressed in the brain, with

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.